Comparison of pravastatin and lovastatin in renal transplant patients receiving cyclosporine
Kliem, V.; Wanner, C.; Eisenhauer, T.; Olbricht, C.J.; Doll, R.; Boddaert, M.; O'Grady, P.; Krekler, M.; Mangold, B.; Christians, U.
Transplantation Proceedings 28(6): 3126-3128
1996
ISSN/ISBN: 0041-1345 PMID: 8962211 Document Number: 465161
Document emailed within 1 workday
Related Documents
Walker, R.G.; Jones, C.L.; Powell, H.R.; Becker, G.J.; Francis, D.M. 1993: Steroid withdrawal in paediatric renal transplant patients receiving cyclosporine and azathioprine Transplantation Proceedings 25(5): 2883-2885Wilkinson, A.; Ross, E.A.; Hawkins, R.; Danovitch, G. 1987: Measurement of true glomerular filtration rate in renal transplant patients receiving cyclosporine Transplantation Proceedings 19(1 Part 2): 1739-1741
Marumo, F.; Okubo, M.; Yokota, K.; Uchida, H.; Kumano, K.; Endo, T.; Watanabe, K.; Kashiwagi, N. 1988: A clinical study of renal transplant patients receiving triple-drug therapy--cyclosporine A, mizoribine, and prednisolone Transplantation Proceedings 20(1 Suppl 1: 406-409
Vilardell, J.; Oppenheimer, F.; Talbot-Wright, R.; Ricart, M.J.; Andreu, J.; Alcaraz, A.; Carretero, P. 1992: Increased risk of malignant tumors in renal transplant recipients receiving cyclosporine Transplantation Proceedings 24(5): 1948
Veremis, S.A.; Maddux, M.S.; Tang, I.Y.; Millner, S.N.; Prasad, R.; Pollak, R.; Mozes, M.F. 1989: Comparison of cyclosporine (CSA) blood levels and RIA/HPLC ratios among renal transplant patients with normal allograft function, CSA nephrotoxicity or rejection Transplantation Proceedings 21(1 Part 2): 1476-1477
Lal, S.M.; Katyal, A. 2002: Effects of nicotinic acid and lovastatin in combination with cholestyramine in renal transplant patients Missouri Medicine 99(10): 580-584
Keren, A.; Gillis, A.M.; Freedman, R.A.; Baldwin, J.C.; Billingham, M.E.; Stinson, E.B.; Simson, M.B.; Mason, J.W. 1984: Heart transplant rejection monitored by signal-averaged electrocardiography in patients receiving cyclosporine Circulation 70(3 Part 2): I124-I129
Heidecke, C.D.; Nicolaus, C.; Stadler, J.; Florack, G.; Bollschweiler, E.; Hölscher, M. 1987: Measurement of cyclosporine bioactivity in serum of renal transplant recipients: development and comparison with RIA Transplantation Proceedings 19(1 Part 2): 1734-1736
Gibbons, S.; Grevel, J.; Reynolds, K.; Ried, M.; Rutzky, L.P.; Kahan, B.D. 1988: Comparison and correlation of assays for monitoring cyclosporine drug levels in renal transplant recipients Transplantation Proceedings 20(2 Suppl 2: 339-344
Castelao, A.M.; Grinyó, J.M.; Castiñeiras, M.J.; Fiol, C.; Gilvernet, S.; Seron, D.; Torras, J.; Cruzado, J.M.; Alsina, J. 1995: Effect of pravastatin in the treatment of hypercholesterolemia after renal transplantation under cyclosporine and prednisone Transplantation Proceedings 27(4): 2217-2220
Bower, S.; Sear, J.W. 1989: Disposition of alfentanil in patients receiving a renal transplant Journal of Pharmacy and Pharmacology 41(9): 654-657
Lorber, M.I.; Flechner, S.M.; Van Buren, C.T.; Kerman, R.H.; Kahan, B.D. 1985: Cyclosporine, azathioprine, and prednisone as treatment for cyclosporine-induced nephrotoxicity in renal transplant recipients Transplantation Proceedings 17(4 Suppl 1: 282-285
Schulz, A.; Lange, D.E.; Hassell, T.M.; Stone, C.E.; Lison, A.E. 1990: Cyclosporine-induced gingival hyperplasia in renal transplant patients Deutsche Zahnarztliche Zeitschrift 45(7): 414-416
McCauley, J.; Fung, J.J.; Brown, H.; Deballi, P.; Jain, A.; Todo, S.; Starzl, T.E. 1991: Renal function after conversion from cyclosporine to FK 506 in liver transplant patients Transplantation Proceedings 23(6): 3148-3149
Massari, P.U.; Garay, G.; Ulla, M.R. 1994: Bone mineral content in cyclosporine-treated renal transplant patients Transplantation Proceedings 26(5): 2646-2648
Awni, W.M.; Kasiske, B.; Heim-Duthoy, K.; Rose, M.; Rao, V.K.; Bloom, P.; Ney, A.; Andrisevic, J.; Odland, M.; Andersen, R.C. 1988: Changes in the pharmacokinetics of cyclosporine and three of its metabolites in renal transplant patients early in the posttransplant period Transplantation Proceedings 20(2 Suppl. 2): 623-624
Neumayer, H.H.; Budde, K.; Färber, L.; Haller, P.; Kohnen, R.; Maibücher, A.; Schuster, A.; Vollmar, J.; Waiser, J.; Luft, F.C. 1996: Conversion to microemulsion cyclosporine in stable renal transplant patients: results after one year Clinical Nephrology 45(5): 326-331
Ammons, M.A.; Bauling, P.C.; Weil, R. 1986: Pneumatosis cystoides intestinalis with pneumoperitoneum in renal transplant patients on cyclosporine and prednisone Transplantation Proceedings 18(6): 1868-1870
Tsai, M.-K.; Hu, R.-H.; Lee, C.-J.; Lee, P.-H. 2002: Efficacy of low-dose mycophenolate mofetil therapy for Taiwanese renal transplantation patients receiving primary cyclosporine immunosuppression Journal of the Formosan Medical Association 101(9): 616-621
Senel, M.F.; Van Buren, C.T.; Etheridge, W.B.; Barcenas, C.; Jammal, C.; Kahan, B.D. 1996: Effects of cyclosporine, azathioprine and prednisone on Kimura's disease and focal segmental glomerulosclerosis in renal transplant patients Clinical Nephrology 45(1): 18-21